Wells Fargo & Company BRIDGEBIO PHARMA INC Transaction History

Wells Fargo & Company

24,355,000

Previous 21,111,000 15.37%

Previous $0 NaN%

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	N/A	3,244,000 Added 15.37%	24,355,000 $0
Q1 2025 May 13, 2025	BUY	N/A	6,000,000 Added 39.71%	21,111,000 $0
Q4 2024 Feb 12, 2025	BUY	N/A	4,414,000 Added 41.26%	15,111,000 $0
Q3 2024 Nov 13, 2024	BUY	N/A	37,000 Added 0.35%	10,697,000 $0
Q2 2024 Aug 13, 2024	SELL	N/A	-1,712,000 Reduced 13.84%	10,660,000 $0
Q1 2024 May 10, 2024	SELL	N/A	-4,245,000 Reduced 25.55%	12,372,000 $0
Q4 2023 Feb 09, 2024	BUY	N/A	56,000 Added 0.34%	16,617,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	7,734,000 Added 87.62%	16,561,000 $0
Q2 2023 Aug 15, 2023	BUY	N/A	300,000 Added 3.52%	8,827,000 $0
Q1 2023 May 12, 2023	SELL	N/A	-2,000,000 Reduced 19.0%	8,527,000 $0
Q2 2022 Aug 12, 2022	BUY	N/A	1,000,000 Added 10.5%	10,527,000 $4.26 Million
Q1 2022 May 16, 2022	BUY	N/A	9,527,000 New	9,527,000 $4.53 Million

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.